Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;49:1217-1219
Published online before print April 23, 2007, doi: 10.1161/HYPERTENSIONAHA.107.088146
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
49/6/1217    most recent
HYPERTENSIONAHA.107.088146v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schillaci, G.
Right arrow Articles by Pirro, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schillaci, G.
Right arrow Articles by Pirro, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
*Obesity
Related Collections
Right arrow Obesity
Right arrow Clinical Studies
Right arrow Epidemiology
Right arrowRelated Article

(Hypertension. 2007;49:1217.)
© 2007 American Heart Association, Inc.


Editorial Commentaries

Hypoadiponectinemia

A Novel Link Between Obesity and Hypertension?

Giuseppe Schillaci; Matteo Pirro

From the Unit of Internal Medicine, Angiology and Arteriosclerosis Disease, University of Perugia, Perugia, Italy.

Correspondence to Giuseppe Schillaci, Internal Medicine, Angiology and Arteriosclerosis Disease, University of Perugia Medical School, Hospital "S Maria della Misericordia," piazzale Menghini, 1, IT-06129 Perugia, Italy. E-mail skill@unipg.it


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Hypertension is a public health challenge of increasing importance because of its high frequency and concomitant risk of cardiovascular and renal disease. It has been estimated that the worldwide prevalence of hypertension was 972 million in 2000, and this number will increase by 60% by the year 2025.1 A large body of evidence indicates that the increasing prevalence of hypertension is sustained by the escalation of overweight and obesity. Actually, most hypertensive patients are also overweight or obese,2 and this may contribute to further deteriorate their cardiovascular risk profile. Similar to hypertension, obesity is independently associated with numerous adverse cardiovascular outcomes, and, most importantly, adipose tissue expansion and hypertension have a synergistic negative impact on cardiovascular prognosis. Hence, the hypertension–obesity pandemic imposes today a considerable burden on societies and healthcare systems that one can reasonably expect to increase further in the next years. The importance of preventing hypertension underscores the critical role of a better understanding of the most common mechanisms underlying its development.

The association between obesity and hypertension has been recognized for many decades,2 and an almost linear relation appears between body mass index and systolic and diastolic blood pressures, at least over a body mass index range from 16 to 31 kg/m2.3 Also, risk estimates from the Framingham Heart Study suggest that {approx}78% of the hypertension cases in men and 65% in women can be directly attributed to obesity.4 Further evidence for a consistent link between adiposity and hypertension comes from studies showing that weight gain . . . [Full Text of this Article]


Related Article:

Hypoadiponectinemia as a Predictor for the Development of Hypertension: A 5-Year Prospective Study
Wing-Sun Chow, Bernard M.Y. Cheung, Annette W.K. Tso, Aimin Xu, Nelson M.S. Wat, Carol H.Y. Fong, Liza H.Y. Ong, Sidney Tam, Kathryn C.B. Tan, Edward D. Janus, Tai-Hing Lam, and Karen S.L. Lam
Hypertension 2007 49: 1455-1461. [Abstract] [Full Text] [PDF]